Drug Shortage Report for CEFOXITIN FOR INJECTION

Last updated on 2025-04-08 History
Report ID 229942
Drug Identification Number 02128195
Brand name CEFOXITIN FOR INJECTION
Common or Proper name CEFOXITIN INJECTION 2 GRAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFOXITIN
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10pk
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-06
Estimated end date 2025-04-30
Actual end date 2025-04-07
Shortage status Resolved
Updated date 2025-04-08
Company comments Product now available
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2025-04-08 English Compare
v20 2025-04-07 French Compare
v19 2025-04-07 English Compare
v18 2025-04-02 French Compare
v17 2025-04-02 English Compare
v16 2025-03-20 French Compare
v15 2025-03-20 English Compare
v14 2024-11-14 French Compare
v13 2024-11-14 English Compare
v12 2024-10-24 French Compare
v11 2024-10-24 English Compare
v10 2024-09-19 French Compare
v9 2024-09-19 English Compare
v8 2024-08-30 French Compare
v7 2024-08-30 English Compare
v6 2024-06-20 French Compare
v5 2024-06-20 English Compare
v4 2024-06-13 French Compare
v3 2024-06-13 English Compare
v2 2024-06-07 French Compare

Showing 1 to 20 of 21